GLP-1 medications continue to surge in popularity, offering effective solutions for weight management, Type 2 diabetes, and other emerging indications. While these drugs show significant clinical benefits, their skyrocketing costs present a major challenge for self-insured employers. Current solutions fall short at addressing the core issue: ensuring members have access to these medications when appropriate while supporting long-term health and sustainable cost management.

During this webinar, we’ll explore a balanced, more intentional approach to GLP-1 management — one that goes beyond cost-shifting to focus on evidence-based prescribing, member engagement and sustainable outcomes. We’ll discuss:

• How Quantum Health’s new model ensures the right members start GLP-1 therapy through clinically guided readiness assessments and targeted support
• What self-insured employers can do to balance cost control with member outcomes in this rapidly evolving market
• How a human-centered, behavior-first strategy leads to long-term cost savings
• How to successfully graduate members from GLP-1s and onto sustainable, lower-cost strategies 

Speakers

Bill Golden

Chief Commercial Officer
Quantum Health

Stanley Crittenden

Chief Medical Officer
Quantum Health

Richard Frank, M.D., MHSA

Chief Medical Officer
Vida Health